300970 华绿生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)6.4997.048-3.1301.9855.325
总资产报酬率 ROA (%)4.3824.619-2.1501.4814.058
投入资产回报率 ROIC (%)4.8715.157-2.4101.6444.412

边际利润分析
销售毛利率 (%)32.13316.0995.95913.52216.320
营业利润率 (%)28.7869.588-4.2712.72710.767
息税前利润/营业总收入 (%)27.8419.897-3.5212.6619.376
净利润/营业总收入 (%)28.7939.231-4.3042.64710.333

收益指标分析
经营活动净收益/利润总额(%)97.46393.84391.021140.93885.129
价值变动净收益/利润总额(%)0.0000.000-0.1961.3905.254
营业外收支净额/利润总额(%)0.024-3.8180.434-3.021-1.175

偿债能力分析
流动比率 (X)4.1353.4042.6062.6863.837
速动比率 (X)3.1272.4861.7251.8812.987
资产负债率 (%)29.71632.29334.09826.00523.118
带息债务/全部投入资本 (%)13.70713.71915.00310.08813.940
股东权益/带息债务 (%)553.897538.882482.281814.013599.162
股东权益/负债合计 (%)230.633205.281189.795280.865329.901
利息保障倍数 (X)-29.26914.938-4.577193.875-7.407

营运能力分析
应收账款周转天数 (天)3.7534.2566.1715.62811.833
存货周转天数 (天)73.23069.92671.26472.14175.843